Sanofi (NASDAQ:SNY) Given Average Recommendation of “Hold” by Brokerages

Sanofi (NASDAQ:SNY) has earned a consensus rating of “Hold” from the fifteen research firms that are presently covering the stock, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, nine have given a hold recommendation, three have given a buy recommendation and two have given a strong buy recommendation to the company. The average 12 month price target among brokerages that have covered the stock in the last year is $49.50.

SNY has been the topic of a number of recent research reports. Weiss Ratings downgraded shares of Sanofi from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, August 3rd. Morgan Stanley set a $49.00 target price on shares of Sanofi in a report on Wednesday, July 8th. Finally, Wall Street Zen downgraded shares of Sanofi from a “buy” rating to a “hold” rating in a research report on Sunday, August 9th.

Hedge Funds Weigh In On Sanofi

Hedge funds have recently modified their holdings of the stock. QRG Capital Management Inc. grew its stake in Sanofi by 18.6% in the fourth quarter. QRG Capital Management Inc. now owns 111,465 shares of the company’s stock valued at $5,402,000 after purchasing an additional 17,511 shares in the last quarter. Assetmark Inc. boosted its holdings in shares of Sanofi by 14.8% in the 1st quarter. Assetmark Inc. now owns 509,464 shares of the company’s stock valued at $24,546,000 after buying an additional 65,796 shares during the last quarter. AMG National Trust Bank bought a new position in shares of Sanofi in the first quarter valued at $2,719,000. Leuthold Group LLC bought a new position in shares of Sanofi in the fourth quarter valued at $4,548,000. Finally, Strategic Investment Advisors MI acquired a new position in Sanofi during the first quarter worth $1,398,000. Institutional investors own 14.03% of the company’s stock.

Sanofi Stock Down 1.3%

NASDAQ:SNY opened at $44.84 on Friday. The company has a debt-to-equity ratio of 0.21, a quick ratio of 0.64 and a current ratio of 0.99. The company has a market cap of $108.71 billion, a PE ratio of 23.48, a PEG ratio of 1.39 and a beta of 0.35. Sanofi has a 52-week low of $40.89 and a 52-week high of $52.68. The stock has a 50-day simple moving average of $43.62 and a 200 day simple moving average of $44.83.

Sanofi (NASDAQ:SNY) last announced its earnings results on Thursday, July 30th. The company reported $2.41 earnings per share (EPS) for the quarter. Sanofi had a return on equity of 14.19% and a net margin of 8.66%.The business had revenue of $13.36 billion for the quarter. During the same period in the prior year, the business posted $3.24 EPS. The firm’s quarterly revenue was up 16.0% compared to the same quarter last year. On average, sell-side analysts expect that Sanofi will post 5.01 EPS for the current fiscal year.

About Sanofi

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines.